Genetic Dementia Risk and AR Therapy-Associated Cognitive Effects: AFT-47 Darolutamide vs Enzalutamide. Presented by @charlesryanmd @MSKCancerCenter. #ESMO26 written coverage by @zklaassen_md > https://bit.ly/47xHtU7 @myESMO #ProstateCancer #GUOnc